Polyamine pools in HIV-infected cells

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 17, Issue 2, 1998, Pages 101-103

  White, E Lucile ^a   Rose, Lucy M ^a   Allan, Paula W ^a   Buckheit Jr , Robert W ^a   Shannon, William M ^a   Secrist III, John A ^a  

^a SOUTHERN RESEARCH INSTITUTE   (United States)

Author keywords

HIV 1; Ornithine decarboxylase; Polyamines; Putrescine; S adenosylmethionin decarboxylase; Spermidine; Spermine

Indexed keywords

3 AMINOOXYPROPYLAMINE; 5' DEOXY 5' [(3 HYDRAZINOPROPYL)METHYLAMINO]ADENOSINE; 5' DEOXY 5' [2 (HYDRAZINOCARBONYLETHYL)METHYLAMINO]ADENOSINE; 5' DEOXY 5' [[2 [(HYDRAZINOCARBONYL) AMINO]ETHYL]METHYLAMINO]ADENOSINE; 5' [(4 AMINOOXYBUTYL)METHYLAMINO] 5' DEOXYADENOSINE; ADENOSYLMETHIONINE DECARBOXYLASE; ANTIVIRUS AGENT; EFLORNITHINE; ORNITHINE DECARBOXYLASE; ORNITHINE DECARBOXYLASE INHIBITOR; PUTRESCINE; SPERMINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CELLULAR DISTRIBUTION; DOSE RESPONSE; DRUG EFFECT; ENZYME INHIBITION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEUKEMIA L 1210; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; VIRUS INHIBITION; VIRUS REPLICATION;

EID: 0032006907     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199802010-00001     Document Type: Article

References (24)

1. Pegg AE, McCann PP. Polyamine metabolism and function. Am J Physiol 1982;243:C212-21.
2. Sjoerdsma A, Schechter PJ. Chemotherapeutic implications of polyamine biosynthesis inhibition. Clin Pharmacol Ther 1984;35. 287-300.
3. Tabor CW, Tabor H. Polyamines in microorganisms. Microbiol Rev 1985;49:81-99.
4. Porter CW, Sufrin JR. Interference with polyamine biosynthesis and/or function by analogs of polyamines or methionine as a potential anticancer chemotherapeutic strategy. Anticancer Res 1986; 6:525-42.
5. Pegg AE. Recent advances in the biochemistry of polyamines in eukaryotes. Biochem J 1986;234:249-62.
6. Tyms AE, Scamans E, Williamson JD. Polyamine metabolism in MRC5 cells infected with different herpes viruses. Biochem Biophys Res Commun 1979;86:312-8.
7. Tyms AE, Rawal BK, Naim HM, Williamson JD. The antiviral effect of inhibitors of polyamine metabolism. In: Bachrach U, Kaye A, Chayen R, eds. Advances in polyamine research, vol 4. New York: Raven Press, 1983:507-17.
8. Gibson W, van Breemen R, Fields A, LaFemina R, Irmiere A. D,L-α-Difluoromethylornithine inhibits human cytomegalovirus replication. J Virol 1984;50:145-54.
9. Tyms AS, Williamson JD. Inhibition of viral polyamine biosynthesis. In: McCann PP, Pegg AE, Sjoerdsma A, eds. Inhibition of polyamine metabolism. Biological significance and basis for new therapies. Orlando: Academic Press, 1987:277-304.
10. Clarke JR, Tyms AS. Polyamine biosynthesis in cells infected with different clinical isolates of human cytomegalovirus. J Med Virol 1991;34:212-6.
11. Colombatto S, DeAgostini M, Corsi D, Sinicco A. Polyamines in lymphocytes from patients infected by human immunodeficiency virus. Biol Chem Hoppe-Seyler 1989;370:745-8.
12. Don S, Bachrach U. Polyamine metabolism in normal and in virus-transformed chick embryo fibroblasts. Cancer Res 1975;35:3618-22.
13. Bachrach U, Wiener H. Increase in S-adenosyl-L-methionine decarboxylase activity during the transformation of chick embryo fibroblasts by Rous sarcoma virus. Int J Cancer 1980;26:75-8.
14. Höltta E, Vartio T, Jänne J, Vaheri A, Hovi T. Temperature-dependent and transformation-associated changes in polyamine metabolism in normal and Rous sarcoma virus-infected chick embryo fibroblasts. Biochem Biophys Acta 1981;677:1-6.
15. Kabra P, Lee H. Solid-phase extraction and determination of dansyl derivatives of unconjugated and acetylated polyamines by reverse-phase liquid chromatography: improved separation systems for polyamines in cerebrospinal fluid, urine and tissue. J Chromatogr 1986;380:19-32.
16. Buckheit RW Jr, Hollingshead MG, Germany-Decker J, et al. Thiazolobenzimidazole: biological and biochemical anti-retroviral activity of a new nonnucleoside reverse transcriptase inhibitor. Antiviral Res 1993;21:247-65.
17. Metcalf BW, Bey P, Danzin C, Jung MJ, Casara P, Vevert JP. Catalytic irreversible inhibition of mammalian ornithine decarboxylase (E.C. 4.1.1.17) by substrate and product analogues. J Am Chem Soc 1978;100:2551-3.
18. Khomutov RM, Hyvönen T, Karvonen E, et al. 1-Aminooxy-3-aminopropane, a new and potent inhibitor of polyamine biosynthesis that inhibits ornithine decarboxylase, adenosylmethionine decarboxylase and spermidine synthase. Biochem Biophys Res Commun 1985;130:596-602.
19. Pegg AE, Jones DB, Secrist JA III. Effect of inhibitors of S-adenosylmethionine decarboxylase on polyamine content and growth of L1210 cells. Biochemistry 1988;27:1408-15.
20. Elo H. Adenosylmethionine decarboxylase inhibitors - lack of activity against cytopathic effects of HIV. Exp Chemother 1990;90: 373-80.
21. Secrist JA III. New substrate analogues as inhibitors of S-adenosylmethionine decarboxylase. Nucleosides Nucleotides 1987; 6:73-83.
22. Pegg AE, Pöso H. S-Adenosylmethionine decarboxylase (rat liver). Methods Enzymol 1983;94:234-9.
23. White EL, Arnett G, Secrist JA III, Shannon WM. Characterization of S-adenosylmethionine decarboxylase induced by human cytomegalovirus infection. Virus Res 1994;31:255-63.
24. Sheely JE, Pegg AE. Ornithine decarboxylase (mouse kidney). Methods Enzymol 1983;94:158-61.